Pioneering a wearable brain-first neurotechnology, Nettle, that provides non-hormonal brain stimulation to reduce menstrual pain, low mood, and brain fog.
Funding, launches and regulatory moves across the neurotech startup map.
Subscribed. Check your inbox to confirm.
•
Neurofounders Insights
$ Funding -
Seed
MODALITY
tDCS/tES
FORM FACTOR
Headset/cap
INTERFACE DEPTH
Non-invasive
INDICATION
Women's health
TARGET USER
Mixed
REGULATORY STAGE
CE-Marked
Samphire Neuroscience is differentiated by applying non-hormonal brain stimulation to women’s health symptoms such as menstrual pain, low mood, and brain fog. The indication choice is commercially interesting because it opens a relatively under-addressed segment of consumer-adjacent clinical neurotechnology.
Samphire Neuroscience’s Nettle headband gained an expanded UK and EU intended purpose covering mood symptoms of PMDD. In a 42-person sham-controlled, nonrandomized study, GAD-7 anxiety scores fell 6.4 points versus 2.1 with sham.